These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36801535)

  • 1. Association between emergency department sepsis order set design and delay to second dose piperacillin-tazobactam administration.
    Erickson RM; Sacha GL; Bauer SR; Fertel BS; Dettmer MR; Wesolek JL; Campbell MJ
    Am J Emerg Med; 2023 May; 67():41-47. PubMed ID: 36801535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating vancomycin and piperacillin-tazobactam in ED patients with severe sepsis and septic shock.
    Le C; Chu F; Dunlay R; Villar J; Fedullo P; Wardi G
    Am J Emerg Med; 2018 Aug; 36(8):1380-1385. PubMed ID: 29321120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Intravenous Push Piperacillin-Tazobactam on Time to Antibiotic Administration in Emergency Department Patients with Sepsis.
    Alrashed MA; Kang N; Perona SJ; Torabi MR; Borgstrom MC
    J Pharm Pract; 2023 Aug; 36(4):756-760. PubMed ID: 35220826
    [No Abstract]   [Full Text] [Related]  

  • 4. Implementation of an Electronic Alert to Improve Timeliness of Second Dose Antibiotics for Patients With Suspected Serious Infections in the Emergency Department: A Quasi-Randomized Controlled Trial.
    Lee AH; McEvoy DS; Stump T; Stevens R; Deng H; Rubins D; Filbin M; Hayes BD; Rhee C; Dutta S
    Ann Emerg Med; 2023 Apr; 81(4):485-491. PubMed ID: 36669909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Piperacillin-Tazobactam Dosing in Septic Shock Patients Using Real-World Evidence: An Observational, Retrospective Cohort Study.
    Allen JM; Surajbali D; Q Nguyen D; Kuczek J; Tran M; Hachey B; Feild C; Shoulders BR; Smith SM; Voils SA
    Ann Pharmacother; 2023 Jun; 57(6):653-661. PubMed ID: 36154486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed Second Dose Antibiotics for Patients Admitted From the Emergency Department With Sepsis: Prevalence, Risk Factors, and Outcomes.
    Leisman D; Huang V; Zhou Q; Gribben J; Bianculli A; Bernshteyn M; Ward MF; Schneider SM
    Crit Care Med; 2017 Jun; 45(6):956-965. PubMed ID: 28328652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
    D'Angelica MI; Ellis RJ; Liu JB; Brajcich BC; Gönen M; Thompson VM; Cohen ME; Seo SK; Zabor EC; Babicky ML; Bentrem DJ; Behrman SW; Bertens KA; Celinski SA; Chan CHF; Dillhoff M; Dixon MEB; Fernandez-Del Castillo C; Gholami S; House MG; Karanicolas PJ; Lavu H; Maithel SK; McAuliffe JC; Ott MJ; Reames BN; Sanford DE; Sarpel U; Scaife CL; Serrano PE; Smith T; Snyder RA; Talamonti MS; Weber SM; Yopp AC; Pitt HA; Ko CY
    JAMA; 2023 May; 329(18):1579-1588. PubMed ID: 37078771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Duration and Empiric Antibiotic Choice of Post-Operative Treatment in Abdominal Sepsis.
    Surat G; Meyer-Sautter P; Rüsch J; Braun-Feldweg J; Germer CT; Lock JF
    Surg Infect (Larchmt); 2022 Jun; 23(5):444-450. PubMed ID: 35532964
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
    Hagel S; Bach F; Brenner T; Bracht H; Brinkmann A; Annecke T; Hohn A; Weigand M; Michels G; Kluge S; Nierhaus A; Jarczak D; König C; Weismann D; Frey O; Witzke D; Müller C; Bauer M; Kiehntopf M; Neugebauer S; Lehmann T; Roberts JA; Pletz MW;
    Intensive Care Med; 2022 Mar; 48(3):311-321. PubMed ID: 35106617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of extended emergency department stay on antibiotic re-dosing delays and outcomes in sepsis.
    Harpenau TL; Bhatti SN; Hoffman BM; Kirsch WB
    Am J Emerg Med; 2022 May; 55():32-37. PubMed ID: 35255455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
    Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
    Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdialysis as a safe and feasible method to study target-site piperacillin-tazobactam disposition in septic piglets and children.
    Hermans E; Devreese M; Zeitlinger M; Dhont E; Verougstraete N; Colman R; Vande Walle J; De Paepe P; De Cock PA
    Int J Antimicrob Agents; 2023 Nov; 62(5):106970. PubMed ID: 37716576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department.
    Miller J; Hall B; Wilson K; Cobian J
    Am J Emerg Med; 2020 Dec; 38(12):2570-2573. PubMed ID: 31932126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adding piperacillin-tazobactam to automated dispensing cabinets on promptness of first-dose antibiotics in hospitalized patients.
    Lo A; Zhu JN; Richman M; Joo J; Chan P
    Am J Health Syst Pharm; 2014 Oct; 71(19):1663-7. PubMed ID: 25225451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia.
    Weber N; Jackson K; McWhinney B; Ungerer J; Kennedy G; Lipman J; Roberts JA
    J Infect Chemother; 2019 Jul; 25(7):503-508. PubMed ID: 30879981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of First-Dose, Intravenous Push Penicillins and Carbapenems in the Emergency Department.
    Academia EC; Jenrette JE; Mueller SW; McLaughlin JM
    J Pharm Pract; 2022 Jun; 35(3):369-376. PubMed ID: 33302785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study.
    Rando E; Salvati F; Sangiorgi F; Catania F; Leone E; Oliva A; Di Gennaro F; Fiori B; Cancelli F; Figliomeni S; Bobbio F; Sacco F; Bavaro DF; Diella L; Belati A; Saracino A; Mastroianni CM; Fantoni M; Murri R
    J Antimicrob Chemother; 2024 Feb; 79(2):453-461. PubMed ID: 38169441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delays in antibiotic redosing: Association with inpatient mortality and risk factors for delay.
    Kemmler CB; Sangal RB; Rothenberg C; Li SX; Shofer FS; Abella BS; Venkatesh AK; Foster SD
    Am J Emerg Med; 2021 Aug; 46():63-69. PubMed ID: 33735698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.
    Qian ET; Casey JD; Wright A; Wang L; Shotwell MS; Siemann JK; Dear ML; Stollings JL; Lloyd BD; Marvi TK; Seitz KP; Nelson GE; Wright PW; Siew ED; Dennis BM; Wrenn JO; Andereck JW; Han JH; Self WH; Semler MW; Rice TW;
    JAMA; 2023 Oct; 330(16):1557-1567. PubMed ID: 37837651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.